Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER LONDON LTD
Citação
CLINICAL RHEUMATOLOGY, v.40, n.4, p.1497-1505, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives This study aimed to investigate subclinical left ventricle (LV) systolic dysfunction in juvenile dermatomyositis (JDM) using two-dimensional speckle-tracking echocardiography (2DST). Possible associations between LV deformation impairment and disease activity/cumulative damage were also evaluated. Methods Thirty-fiveconsecutive JDM patients without cardiac symptoms and 35 healthy volunteers were enrolled. Clinical data were collected from medical records, and echocardiograms were performed by a pediatric cardiologist, unaware of patients' conditions. Results Patients and controls had similar age (12.6 +/- 0.7 vs.12.5 +/- 0.6;p= 0.97) and gender (11F:24M vs.11F:24M;p= 1.0). Median of JDM duration was 4.6 (0.04-17.6) years, and only 6/35 (17%) had active disease (disease activity score (DAS > 3)). Conventional echocardiogram revealed preserved LV ejection fraction (EF) (>= 55%) in all individuals. In JDM, 2DST identified reduction of LV longitudinal [-22(-17.2 to -27.9) % vs. -23(-20.8 to -27.4) %;p= 0.028)] and circumferential -23.9 +/- 2.8% vs. -26.7 +/- 2.9%;p= 0.0002) strain. Lower longitudinal strain was associated with DAS >3 -19.9(-17.2 to -26.5)% vs. -22.1-18.9 to -27.9)%;p= 0.046], MDI extent > 0 [-19(-17.2 to -22.5)% vs. -22.1-19.2 to -27.9)%;p= 0.0008], MDI severity > 0 [-19(-17.2 to -22.1)% vs. -22.3(-20.3 to -27.9)%;p= 0.0001] and calcinosis[-20.6(-17.2 to -23)% vs. -22.3(-20.3 to -27.9)%;p= 0.03]. Lower circumferential strain was associated with MDI extent > 0 (-22.1 +/- 3.87% vs. -24.4 +/- 2.3%;p= 0.039), MDI severity > 0 (-21.7 +/- 3% vs. 24.7 +/- 2.3%;p= 0.004) and calcinosis (-22.5 +/- 3.3% vs. -24.8 +/- 2.1%;p= 0.02). There was a negative correlation between longitudinal strain and cumulative dose of prednisone (r= -0.44;p= 0.009) and methotrexate (r= -0.33;p= 0.0008). Conclusions LV 2DST detected early systolic myocardial compromise in asymptomatic pediatric JDM patients, with preserved EF. Longitudinal strain impairment was associated with disease activity and cumulative damage, whereas circumferential strain impairment was associated exclusively with cumulative damage.
Palavras-chave
Echocardiography, Juvenile dermatomyositis, Myocardial damage, Two-dimensional speckle tracking
Referências
  1. Apaz MT, 2009, ARTHRIT RHEUM-ARTHR, V61, P509, DOI 10.1002/art.24343
  2. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  3. Bottai M, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000507
  4. Caforio ALP, 2017, EUR HEART J, V38, P2649, DOI 10.1093/eurheartj/ehx321
  5. Dulcan M, 1994, NOMENCLATURE CRITERI, P253
  6. Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P212, DOI 10.1016/j.echo.2003.12.005
  7. Guerra F, 2017, J RHEUMATOL, V44, P815, DOI 10.3899/jrheum.161311
  8. Gupta R, 2011, INT J CARDIOL, V148, P261, DOI 10.1016/j.ijcard.2010.08.013
  9. HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5
  10. Huber AM, 2004, ARTHRITIS RHEUM, V50, P1595, DOI 10.1002/art.20179
  11. Klatchoian DA, 2008, J PEDIAT-BRAZIL, V84, P308, DOI [10.1590/S0021-75572008000400005, 10.2223/JPED.1788]
  12. Kountz-Edwards S, 2017, CHRONIC ILLN, V13, P262, DOI 10.1177/1742395317690034
  13. Lazarevic D, 2013, ANN RHEUM DIS, V72, P686, DOI 10.1136/annrheumdis-2012-201483
  14. Leal GN, 2016, SCAND J RHEUMATOL, V45, P202, DOI 10.3109/03009742.2015.1063686
  15. Leal GN, 2015, LUPUS, V24, P613, DOI 10.1177/0961203314563135
  16. Leal GN, 2019, ARQ BRAS CARDIOL IMA, V32, P29, DOI [10.5935/2318-8219.20190008, DOI 10.5935/2318-8219.20190008]
  17. Levy PT, 2016, J AM SOC ECHOCARDIOG, V29, P209, DOI 10.1016/j.echo.2015.11.016
  18. Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019
  19. Mavrogeni S, 2011, JACC-CARDIOVASC IMAG, V4, P1324, DOI 10.1016/j.jcmg.2011.05.009
  20. Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015
  21. Rider L, 2016, TXB PEDIAT RHEUMATOL, P351
  22. Rider LG, 2011, ARTHRIT CARE RES, V63, pS118, DOI 10.1002/acr.20532
  23. Neto NSR, 2010, REV BRAS REUMATOL, V50, P99, DOI 10.1590/S0482-50042010000300010
  24. Schwartz T, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2016-000291
  25. Schwartz T, 2014, ANN RHEUM DIS, V73, P1805, DOI 10.1136/annrheumdis-2013-203279
  26. Schwartz T, 2011, ANN RHEUM DIS, V70, P766, DOI 10.1136/ard.2010.137968
  27. Wienke J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02951